We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.5B
AUM Growth
+$378M
Cap. Flow
+$252M
Cap. Flow %
1.74%
Top 10 Hldgs %
26.25%
Holding
735
New
61
Increased
261
Reduced
285
Closed
31

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$73.6M
2
GILD icon
Gilead Sciences
GILD
+$57M
3
MSFT icon
Microsoft
MSFT
+$44.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38.6M
5
NU icon
Nu Holdings
NU
+$38M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$112M
2
RY icon
Royal Bank of Canada
RY
+$44.3M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.1M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$38.9M
5
MRK icon
Merck
MRK
+$31.7M

Sector Composition

Rank Sector Weight
1 Technology 30.32%
2 Healthcare 28.88%
3 Consumer Discretionary 8.63%
4 Financials 8.52%
5 Industrials 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITW icon
251
Illinois Tool Works
ITW
$84.1B
$9.85M 0.07%
37,608
+8,929
+31% +$2.14M
IMCR icon
252
Immunocore
IMCR
$1.7B
$9.84M 0.07%
144,006
-149,005
-51% -$7.74M
INSM icon
253
Insmed
INSM
$22.4B
$9.61M 0.07%
310,200
-15,000
-5% -$389K
ROP icon
254
Roper Technologies
ROP
$40.4B
$9.61M 0.07%
17,629
+1,453
+9% +$748K
CHD icon
255
Church & Dwight Co
CHD
$23.7B
$9.54M 0.07%
100,921
+4,125
+4% +$378K
ORCL icon
256
Oracle
ORCL
$339B
$9.49M 0.07%
90,051
-1,936
-2% -$211K
NRIX icon
257
Nurix Therapeutics
NRIX
$2.45B
$9.48M 0.07%
918,110
-50,000
-5% -$343K
WTRG icon
258
Essential Utilities
WTRG
$11.5B
$9.14M 0.06%
244,680
+41,801
+21% +$1.46M
GWRE icon
259
Guidewire Software
GWRE
$13.9B
$9.03M 0.06%
+82,818
New +$7.9M
TMUS icon
260
T-Mobile US
TMUS
$195B
$8.96M 0.06%
55,893
-19,806
-26% -$2.93M
ALPN
261
DELISTED
Alpine Immune Sciences Inc
ALPN
$8.96M 0.06%
+470,000
New +$6.53M
KKR icon
262
KKR & Co
KKR
$89.1B
$8.95M 0.06%
108,030
+72,008
+200% +$4.88M
MCO icon
263
Moody's
MCO
$83.7B
$8.9M 0.06%
22,797
+3,404
+18% +$1.18M
ZLAB icon
264
Zai Lab
ZLAB
$2.07B
$8.88M 0.06%
+325,013
New +$8.58M
BKNG icon
265
Booking.com
BKNG
$156B
$8.85M 0.06%
62,375
-29,800
-32% -$3.72M
KYMR icon
266
Kymera Therapeutics
KYMR
$8.66B
$8.74M 0.06%
343,302
-145,004
-30% -$2.59M
C icon
267
Citigroup
C
$213B
$8.74M 0.06%
169,902
-371,079
-69% -$16.4M
UDR icon
268
UDR
UDR
$12.8B
$8.71M 0.06%
227,412
-149,525
-40% -$5.2M
TGT icon
269
Target
TGT
$66.3B
$8.61M 0.06%
60,487
+26,557
+78% +$3.24M
GPCR icon
270
Structure Therapeutics
GPCR
$3.37B
$8.56M 0.06%
+210,000
New +$12M
ZWS icon
271
Zurn Elkay Water Solutions
ZWS
$8.55B
$8.45M 0.06%
+287,454
New +$8.14M
ARES icon
272
Ares Management
ARES
$28.1B
$8.44M 0.06%
+70,960
New +$7.71M
PHR icon
273
Phreesia
PHR
$689M
$8.41M 0.06%
363,440
+19,272
+6% +$333K
COP icon
274
ConocoPhillips
COP
$144B
$8.37M 0.06%
72,096
-17,648
-20% -$2.06M
ULTA icon
275
Ulta Beauty
ULTA
$21.8B
$8.25M 0.06%
16,843
+6,892
+69% +$2.91M
9 10
11
12 13

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2023 Portfolio in Review

As of Q4 2023, Candriam SCA held 735 positions worth $14.5B, up 2.7% from $14.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Candriam SCA's Q4 2023 filing shows 61 new, 261 increased, 285 reduced and 31 closed positions. Its largest new stake was Nu Holdings: 4,696,438 shares worth $39.1M. The largest sale was Seagen Inc. Common Stock, an estimated $112M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Candriam SCA's largest Q4 2023 buy was Nu Holdings: 4,696,438 shares worth $39.1M.
  • Candriam SCA added most to Visa in Q4 2023, an estimated $73.6M increase.
  • Candriam SCA's biggest Q4 2023 reduction was Royal Bank of Canada, cutting an estimated $44.3M.
  • Candriam SCA fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $112M.
  • Candriam SCA's ten largest holdings make up 26% of its $14.5B portfolio in Q4 2023.
  • Candriam SCA opened 61 new positions and closed 31 in Q4 2023.
  • Candriam SCA's portfolio value rose 2.7% quarter-over-quarter to $14.5B.

Based on Candriam SCA's 13F filing for Q4 2023, filed 14 Feb 2024.